Mr. Bonfiglio is the Founder & Managing Partner of Proteus, LLC – an investment and advisory firm focused solely on Regenerative Medicine. Formed in 2006, Proteus provides fund management and consulting services to the regenerative medicine industry. Proteus works with cell & gene therapy companies across all stages of development from early stage entities to large public companies, as well as governmental organizations pursuing RM initiatives.
Mr. Bonfiglio serves on the Board of Healios KK, one of the largest publicly traded RM companies in Japan. Mr. Bonfiglio is the Chairman of the Board of the Centre for Commercialization of Regenerative Medicine (RM Translation Center in Toronto, Canada). He is on the Board of BioBridge Global (RM Translation Center in San Antonio, Texas). He is on the ISSCR Finance Committee.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.